ukcitymedia news feed

Allied Minds strong progress made in funding the technology portfolio

Allied Minds strong progress made in funding the technology portfolio

Thu 7 Feb 2019 07:13 by about : trading updates - 1 Comments - 717 words


 Allied Minds PLC ("Allied Minds", the "PLC" or the "Group") today provides a trading update ahead of its preliminary results. 


Jill Smith, CEO of Allied Minds, commented "Following strong progress in 2018, each of Spin Memory, HawkEye 360 and Federated Wireless are on track to deliver commercial revenue in 2019. Our strategy to secure strategic investors and commercial partners is paying dividends across our technology portfolio by accelerating commercialisation and creating optionality. We retain large ownership stakes in these companies. Our co-investors now include: Arm Holdings; Applied Materials; Charter Communications; American Tower; Arris International; Raytheon; and Boeing. We are pleased to announce that we have put in place bridge funding for SciFluor and Precision Biopsy. With proactive cost management measures, Allied Minds has cash runway into 2021 and is in a strong position to maximise returns, focusing on supporting its existing portfolio."


Allied Minds had a cash balance at 31 December 2018 estimated at $50 million (excluding cash held at subsidiaries).  This is after allocations of Allied Minds' capital to the SciFluor and Precision Biopsy bridge financings described below. The Directors believe this cash balance is sufficient to support Allied Minds' activities into 2021, before any potential returns from monetisations. Target annualised HQ cash operating expenses will be reduced by $5.6 million, or more than 40%. Recognising this and the challenging capital markets environment for the firm, Jill Smith, CEO of Allied Minds, agreed in December to materially reduce her cash salary for 24 months, commencing with calendar year 2019, and to defer payment of the balance of her salary into 2021. Any earned bonus for 2019 and 2020 will be satisfied in shares rather than cash.


Spin Memory has successfully syndicated to new financial investors substantially all of Allied Minds' backstop commitment to the Spin Memory Series B funding round.  The remaining balance of $2.5 million will be subscribed by Allied Minds in the event that further investors do not take it up.


Allied Minds has agreed together with Woodford Investment Management (WIM) to jointly contribute an aggregate $9 million of convertible bridge financing to SciFluor and Precision Biopsy. Half of this amount is being provided by Allied Minds and half by WIM. In the case of SciFluor, the bridge financing of $4 million will be applied to support the business to the completion of a Series B round to fund Phase II trials for its SF0166 topical eye drop treatment for retinal disease and position the company for growth of its platform. In the case of Precision Biopsy, the bridge financing of $5 million will be applied to support the company to completion of a financing round to fund its pivotal SCORE study. Allied Minds has determined to seek strategic alternatives for its earlier stage life science businesses, LuxCath and Signature Medical, and does not expect to allocate further funds to these businesses.

These articles are summaries / highlights and dont always include all financial news updates. Check at company website INVESTORS INFORMATION for full published results.


07/02/19     8 words

14 Jan 2019 Credit Suisse Neutral 61.80 111.00 Reiterates
03 Oct 2018 Credit Suisse Neutral 61.80 145.00 111.00 Reiterates

Add a comment



Security key:



ukcitymedia news feed

Please take our RSS Feed and news to your Network and message boards. With thanks


ukcitymedia moderates but does not authenicate postings. Users are reminded that shares and all trading instruments by nature do not always prove to be good investments. Readers are reminded to do your own research. delivers UK stock market news, latest shares news, uk financial news, rns news articles, latest business news, latest uk financial news, stockmarket investment news, business news round-ups. director dealings bulletins, stock market reports, share trading articles, latest finance news, broker recommendations, uk city news, latest financial information. does not offer financial advice.